default author photo

Xuejun Chen

National Institutes of Health - Vaccine Research Center

Bethesda, MD 20892-9806

United States

SCHOLARLY PAPERS

3

DOWNLOADS

57

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Potent Anti-Viral Activity of a Trispecific HIV Antibody in SHIV-Infected Monkeys

Number of pages: 57 Posted: 02 Aug 2021
National Institutes of Health - Vaccine Research Center, Sanofi - Massachusetts, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - AIDS and Cancer Virus Program, Government of the United States of America - Vaccine Research Center, Sanofi - Massachusetts, Sanofi - Massachusetts, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, University of Pennsylvania - Perelman School of Medicine, University of Pennsylvania - Perelman School of Medicine, National Institutes of Health - Vaccine Research Center, affiliation not provided to SSRN, National Institutes of Health - Vaccine Research Center, Frederick National Laboratory for Cancer Research - AIDS and Cancer Virus Program, Government of the United States of America - AIDS and Cancer Virus Program, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Sanofi - Massachusetts, Sanofi and National Institutes of Health - Vaccine Research Center
Downloads 34 (1,263,436)
Citation 1

Abstract:

Loading...

2.

The N Terminus of H3-Influenza Hemagglutinin as a Site-of-Vulnerability to Neutralizing Antibody

Number of pages: 50 Posted: 05 Mar 2025
National Institutes of Health - Vaccine Research Center, Columbia University, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Columbia University, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Columbia University, National Institutes of Health - Vaccine Research Center and Independent
Downloads 23 (1,411,822)

Abstract:

Loading...

Cryo-EM, immune focusing, influenza H3 N terminus, peptide immunization, prime-boost, structure-based vaccine design

3.

Anti-Viral Efficacy of a Next-Generation CD4-Binding Site bNAb in SHIVvInfected Animals in the Absence of Anti-Drug Antibody Responses

Posted: 11 May 2022
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center and National Institutes of Health - Vaccine Research Center

Abstract:

Loading...

HIV-1, SHIV, broadly neutralizing antibodies, anti-drug antibody, B cell depletion, anti-CD20, anti-viral